Ledger.Open graph →
SEC Form D · filed July 21, 2021

Fidelis Pharmaceuticals, Inc

Offering
$5.1M
Sold
$5.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NORTH BRUNSWICK, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Barry Levinson · North Brunswick, NJExec · Director · PromoterDennis Steadman · North Brunswick, NJDirectorCynthia Davis · North Brunswick, NJExecSusan Witham · North Brunswick, NJExecSteven Leary · North Brunswick, NJExecAndrew Midler · LA JOLLA, CADirectorKenneth Sylvester · North Brunswick, NJExecEric Schreiber · Miami, FLExecMichael Wells · San Francisco, CAExec · Director · PromoterBarry Levinson · North Brunswick, NJExec · Director · PromoterDennis Steadman · North Brunswick, NJDirectorCynthia Davis · North Brunswick, NJExecSusan Witham · North Brunswick, NJExecSteven Leary · North Brunswick, NJExecAndrew Midler · Santa Clara, CADirectorKenneth Sylvester · North Brunswick, NJExecEric Schreiber · Miami, FLExecMichael Wells · SANTA CLARA, CAExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗